| http://www.w3.org/ns/prov#value | - By examining HCV patients treated with a combination therapy of pegylated interferon alpha (PEG???IFN) plus ribavirin, one study found that good responses to the treatment were related to both the VD levels greater than 20???ng/mL and the wild-type VDBP polymorphisms.[67] VDR polymorphisms have also been associated with liver diseases, such as primary biliary cirrhosis.[68, 69] A recent clinical s
|
